三孚新科: 三孚新科：关于公司2023年股票期权激励计划第二个行权期自主行权实施公告

Core Viewpoint - The company has announced the implementation of the second exercise period for its 2023 stock option incentive plan, allowing eligible participants to exercise a total of 1.35 million stock options, which represents 1.39% of the company's total share capital [1][10]. Summary by Relevant Sections Stock Option Incentive Plan - The second exercise period for the 2023 stock option incentive plan is set to allow the exercise of 1.35 million stock options [1][10]. - The stock options will be sourced from the company's A-share ordinary stock issued to the incentive participants [1][11]. - The exercise period is scheduled from June 25, 2025, to June 7, 2026, with the stocks to be listed for trading on the second trading day after the exercise date [1][11]. Approval and Implementation - The board of directors and the supervisory board have approved the achievement of the exercise conditions for the second exercise period [2][6]. - The independent directors have expressed clear agreement on the relevant matters of the incentive plan [2][5]. Exercise Conditions - The exercise conditions for the second period have been met, with nine eligible participants allowed to exercise their options [10][12]. - The exercise price is set at 80.00 yuan per option, and the total number of options granted to the nine participants is 1.35 million [11][12]. Performance Assessment - The performance assessment for the incentive plan spans three fiscal years from 2023 to 2025, with specific revenue growth targets set for each exercise period [10][14]. - The company has established that the performance targets for the second exercise period have been achieved, allowing for a 100% exercise rate for the eligible participants [10][12]. Financial Impact - The company has utilized the Black-Scholes model to calculate the fair value of the stock options, and the exercise of these options is not expected to have a significant impact on the company's financial status or operating results [13][14].